Scott Bizily - Sep 1, 2022 Form 4 Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Signature
/s/ August J. Moretti, Attorney-in-Fact for Scott Bizily
Stock symbol
FDMT
Transactions as of
Sep 1, 2022
Transactions value $
$0
Form type
4
Date filed
9/6/2022, 08:38 PM
Previous filing
Jun 21, 2022
Next filing
Dec 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FDMT Stock Option (Right to Buy) Award $0 +60K $0.00 60K Sep 1, 2022 Common Stock 60K $8.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of September 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.